Stock Rich List
Nasdaq: IMVT

Immunovant insiders

The officers, directors and 10% owners of Immunovant, Inc. who hold the most stock, valued at the live IMVT price.

$32.52
IMVT today −$650K (−1.96%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
14
Their IMVT stock
$3.85B
Market value
$6.92B
Held by ranked insiders
55.6%

Insiders by value of IMVT holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Roivant Sciences Ltd.Director113,317,007$3.69B53.2%Corporate
2Peter SalzmannChief Executive Officer1,178,191$38.3M0.55%3096th
3Frank TortiDirector1,009,228$32.8M0.47%475th
4Julia G. ButchkoChief Development Officer440,959$14.3M0.21%6678th
5Eva Renee BarnettChief Financial Officer396,774$12.9M0.19%7247th
6William L. MaciasChief Medical Officer357,353$11.6M0.17%7852nd
7Mark S. LevineChief Legal Officer319,228$10.4M0.15%8556th
8Eric VenkerChief Executive Officer257,075$8.4M0.12%3014th
9Tiago GiraoChief Financial Officer234,192$7.6M0.11%10730th
10Michael GeffnerChief Medical Officer217,958$7.1M0.10%11299th
11Melanie GloriaChief Operating Officer217,060$7.1M0.10%11328th
12Jay StoutChief Technology Officer198,937$6.5M<0.1%12087th
13Christopher Van TuylChief Legal Officer175,218$5.7M<0.1%13222nd
14Jake BauerDirector38,896$1.3M<0.1%13846th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Immunovant; see each profile for the filing.